News
-
4 September 2020
Early treatment of atrial fibrillation means fewer complications later
Early treatment of chronic arrhythmia reduces the risk of serious cardiovascular complications and death, unlike the current standard protocol of merely monitoring and managing symptoms. These are the conclusions that a team of international researchers will publish today in the prestigious New...
-
31 August 2020
World Congress on regenerative medicine comes to Maastricht
The 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) will take place at the Maastricht Exhibition & Congress Center (MECC) from 31 May to 4 June 2021. This prestigious congress will proceed even if the coronavirus restrictions remain in place...
-
27 August 2020
Nearly three-quarters of patients seizure-free after epilepsy surgery
A large-scale European study on the effectiveness of epilepsy surgery convincingly demonstrates the success of such interventions. These results help in deciding whether an operation is useful in the case of epilepsy. The findings also underpin the idea that operating as quickly as possible...
-
10 August 2020
Analgesic 'bee' gives relief to dialysis patients
A small device shaped like a bee is easing the pain of repeated needle pricks in dialysis patients. This offers a solution in particular for people with a needle phobia. The handy little device is already being used with young patients on the paediatric ward, but Maastricht UMC+ is now introducing...
-
30 July 2020
European grant for developing innovative cancer drug
Scientists at Maastricht UMC+ and Maastro irradiation clinic have received a 150,000 euro grant from the European Research Council to help them bring an innovative cancer drug a step closer to being available to patients. The Maastricht researchers have their eyes on two promising substances that...
-
23 July 2020
Nearly half a million grant to gain better understanding of coronavirus
Bioinformaticians and systems biologists at Maastricht UMC+ and Maastricht University have received almost half a million euros from ZonMw to describe in detail the molecular mechanism of the coronavirus. This should open up new avenues allowing targeted medical treatment of the disease caused by...
-
14 July 2020
Grant of 1.9 million euros for research on feeding ICU patients
Joint research by a total of nine Dutch and Belgian hospitals, led by Maastricht UMC+ and Oost-Limburg Hospital in Genk, which will look at protein-rich tube feeding for ICU patients with the aim of accelerating recovery, has received a grant of 1.9 million euros. The grant was awarded by ZonMw,...
-
8 July 2020
Maastricht researchers awarded Heart Foundation grant
The Dutch Heart Foundation has awarded Maastricht UMC+ researchers Constance Baaten and Pieter Goossens a "Dekker grant" (Dekkerbeurs). These are individual research grants for talented scientists, named after a former Heart Foundation director. With the grant of over 265,000 and 465,000...
-
22 June 2020
New technique used to treat blood clot in the heart
For the first time in Europe, surgeons at Maastricht UMC+ have used a new technique to treat a blood clot in the heart of a patient with atrial fibrillation. Using laparoscopy on the still beating heart, doctors were able to isolate the clot and enclose it in what is called the atrial appendage....
-
12 May 2020
Molecular processes of coronavirus identified
Scientists of Maastricht UMC+ and Maastricht University are closely involved in describing the molecular mechanism of the coronavirus. Based on available research data, molecular interactions that the virus enters into with a human host cell and the influence of the virus on the metabolism and...
